StockData
Celularity Inc logo

Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.57−0.05 (-7.75%)

Close on Nov 17, 2026Market cap $18.53MP/E –Yield –

Celularity revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Celularity's revenue for the twelve months ending Jun 30, 2026 was $18.67M, down 58.1% year over year. For fiscal 2025 it was $26.55M, down 51.0% from the year before. The highest annual figure on record is $54.22M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.55M-51.0%
FY2024Dec 31, 2024$54.22M+138.1%
FY2023Dec 31, 2023$22.77M+26.7%
FY2022Dec 31, 2022$17.98M-15.7%
FY2021Dec 31, 2021$21.34M+49.4%
FY2020Dec 31, 2020$14.28M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.43M-5.3%
Q1 FY2026Mar 31, 2026$3.85M-66.3%
Q4 FY2025Dec 31, 2025$4.10M-77.4%
Q3 FY2025Sep 30, 2025$5.28M-43.2%
Q2 FY2025Jun 30, 2025$5.74M-52.6%
Q1 FY2025Mar 31, 2025$11.43M-22.2%
Q4 FY2024Dec 31, 2024$18.13M+49.7%
Q3 FY2024Sep 30, 2024$9.30M+145.5%
Q2 FY2024Jun 30, 2024$12.11M+312.2%
Q1 FY2024Mar 31, 2024$14.68M+273.1%
Q4 FY2023Dec 31, 2023$12.11M+193.3%
Q3 FY2023Sep 30, 2023$3.79M-8.4%
Q2 FY2023Jun 30, 2023$2.94M-22.2%
Q1 FY2023Mar 31, 2023$3.94M-33.7%
Q4 FY2022Dec 31, 2022$4.13M-15.0%
Q3 FY2022Sep 30, 2022$4.14M-61.1%
Q2 FY2022Jun 30, 2022$3.78M+18.1%
Q1 FY2022Mar 31, 2022$5.94M+123.1%
Q4 FY2021Dec 31, 2021$4.86M+49.7%
Q3 FY2021Sep 30, 2021$10.62M+216.6%
Q2 FY2021Jun 30, 2021$3.20M–
Q1 FY2021Mar 31, 2021$2.66M–
Q4 FY2020Dec 31, 2020$3.24M–
Q3 FY2020Sep 30, 2020$3.36M–

More Celularity figures

See a number that looks wrong?